Panageas KS - Search Results

1

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.

Omuro A, Correa DD, DeAngelis LM, Moskowitz CH, Matasar MJ, Kaley TJ, Gavrilovic IT, Nolan C, Pentsova E, Grommes CC, Panageas KS, Baser RE, Faivre G, Abrey LE, Sauter CS. Omuro A, et al. Among authors: panageas ks. Blood. 2015 Feb 26;125(9):1403-10. doi: 10.1182/blood-2014-10-604561. Epub 2015 Jan 7. Blood. 2015. PMID: 25568347 Free PMC article. Clinical Trial.

2

Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.

Hwu WJ, Lis E, Menell JH, Panageas KS, Lamb LA, Merrell J, Williams LJ, Krown SE, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Hwu WJ, et al. Among authors: panageas ks. Cancer. 2005 Jun 15;103(12):2590-7. doi: 10.1002/cncr.21081. Cancer. 2005. PMID: 15861414 Free article. Clinical Trial.

3

Delayed neurotoxicity in primary central nervous system lymphoma.

Omuro AM, Ben-Porat LS, Panageas KS, Kim AK, Correa DD, Yahalom J, Deangelis LM, Abrey LE. Omuro AM, et al. Among authors: panageas ks. Arch Neurol. 2005 Oct;62(10):1595-600. doi: 10.1001/archneur.62.10.1595. Arch Neurol. 2005. PMID: 16216945

4

Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.

Panageas KS, Elkin EB, DeAngelis LM, Ben-Porat L, Abrey LE. Panageas KS, et al. Cancer. 2005 Dec 1;104(11):2466-72. doi: 10.1002/cncr.21481. Cancer. 2005. PMID: 16240449 Free article.

5

Systemic high-dose intravenous methotrexate for central nervous system metastases.

Lassman AB, Abrey LE, Shah GD, Panageas KS, Begemann M, Malkin MG, Raizer JJ. Lassman AB, et al. Among authors: panageas ks. J Neurooncol. 2006 Jul;78(3):255-60. doi: 10.1007/s11060-005-9044-6. J Neurooncol. 2006. PMID: 16344918 Clinical Trial.

6

Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.

Lamanna N, Kalaycio M, Maslak P, Jurcic JG, Heaney M, Brentjens R, Zelenetz AD, Horgan D, Gencarelli A, Panageas KS, Scheinberg DA, Weiss MA. Lamanna N, et al. Among authors: panageas ks. J Clin Oncol. 2006 Apr 1;24(10):1575-81. doi: 10.1200/JCO.2005.04.3836. Epub 2006 Mar 6. J Clin Oncol. 2006. PMID: 16520464

7

YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.

Hormigo A, Gu B, Karimi S, Riedel E, Panageas KS, Edgar MA, Tanwar MK, Rao JS, Fleisher M, DeAngelis LM, Holland EC. Hormigo A, et al. Among authors: panageas ks. Clin Cancer Res. 2006 Oct 1;12(19):5698-704. doi: 10.1158/1078-0432.CCR-06-0181. Clin Cancer Res. 2006. PMID: 17020973

8

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.

Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM. Abrey LE, et al. Among authors: panageas ks. J Clin Oncol. 2006 Dec 20;24(36):5711-5. doi: 10.1200/JCO.2006.08.2941. Epub 2006 Nov 20. J Clin Oncol. 2006. PMID: 17116938

9

Identifying and addressing barriers to the delivery of optimal therapy for primary central nervous system lymphoma in the broader community.

Abrey LE, Panageas KS. Abrey LE, et al. Among authors: panageas ks. Leuk Lymphoma. 2006 Dec;47(12):2449-52. doi: 10.1080/10428190600881272. Leuk Lymphoma. 2006. PMID: 17169791 Review.

10

Patterns of treatment in older adults with primary central nervous system lymphoma.

Panageas KS, Elkin EB, Ben-Porat L, Deangelis LM, Abrey LE. Panageas KS, et al. Cancer. 2007 Sep 15;110(6):1338-44. doi: 10.1002/cncr.22907. Cancer. 2007. PMID: 17647247 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

283 results

Search Page